7TBA
Pentraxin - ligand complex
7TBA の概要
| エントリーDOI | 10.2210/pdb7tba/pdb |
| 分子名称 | C-reactive protein, [3-(dibutylamino)propyl]phosphonic acid, CALCIUM ION (3 entities in total) |
| 機能のキーワード | inflammation, inhibitor, complex, immune system |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 20 |
| 化学式量合計 | 467989.96 |
| 構造登録者 | |
| 主引用文献 | Zeller, J.,Cheung Tung Shing, K.S.,Nero, T.L.,McFadyen, J.D.,Krippner, G.,Bogner, B.,Kreuzaler, S.,Kiefer, J.,Horner, V.K.,Braig, D.,Danish, H.,Baratchi, S.,Fricke, M.,Wang, X.,Kather, M.G.,Kammerer, B.,Woollard, K.J.,Sharma, P.,Morton, C.J.,Pietersz, G.,Parker, M.W.,Peter, K.,Eisenhardt, S.U. A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein. Embo Mol Med, 15:e16236-e16236, 2023 Cited by PubMed Abstract: C-reactive protein (CRP) is an early-stage acute phase protein and highly upregulated in response to inflammatory reactions. We recently identified a novel mechanism that leads to a conformational change from the native, functionally relatively inert, pentameric CRP (pCRP) structure to a pentameric CRP intermediate (pCRP*) and ultimately to the monomeric CRP (mCRP) form, both exhibiting highly pro-inflammatory effects. This transition in the inflammatory profile of CRP is mediated by binding of pCRP to activated/damaged cell membranes via exposed phosphocholine lipid head groups. We designed a tool compound as a low molecular weight CRP inhibitor using the structure of phosphocholine as a template. X-ray crystallography revealed specific binding to the phosphocholine binding pockets of pCRP. We provide in vitro and in vivo proof-of-concept data demonstrating that the low molecular weight tool compound inhibits CRP-driven exacerbation of local inflammatory responses, while potentially preserving pathogen-defense functions of CRP. The inhibition of the conformational change generating pro-inflammatory CRP isoforms via phosphocholine-mimicking compounds represents a promising, potentially broadly applicable anti-inflammatory therapy. PubMed: 36468184DOI: 10.15252/emmm.202216236 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






